Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 16, 2020
The Cost and the Effectiveness of Cholangiography for the Diagnosis and Treatment of a Bile Duct Injury After Difficult Identification of the Cystic DuctFrédéric Borie, Muriel Mathonnet, Alain Deleuze, et al.
Scientific Reports|July 20, 2022
The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitusZeinab Tarhini, Kamelia Manceur, Julien Magne, et al.
Mediators of Inflammation|June 19, 2004
Elevated plasma phospholipase A2 and platelet-activating factor acetylhydrolase activity in colorectal cancerYves Denizot, Véronique Truffinet, Stéphane Bouvier, et al.
World Journal of Gastroenterology|May 24, 2006
Platelet-activating factor in cirrhotic liver and hepatocellular carcinomaMuriel Mathonnet, Bernard Descottes, Denis Valleix, et al.
Acta Chirurgica Belgica|January 27, 2021
From abdominal pain to a diagnosis of primary sclerosing encapsulating peritonitis and its management, a case reportMargaux Mekann Bouv-Hez, Aurélie Charissoux, Stephane Bouvier, et al.
Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.
Cancer Science|June 15, 2020
5-Fluorouracil resistance mechanisms in colorectal cancer: From classical pathways to promising processesSabrina Blondy, Valentin David, Mireille Verdier, et al.
Cytotechnology|September 8, 2010
Oncogramme, a new individualized tumor response testing method: application to colon cancerElodie Loum, Stephanie Giraud, Barbara Bessette, et al.
European Journal of Endocrinology|July 5, 2005
Platelet-activating factor and human thyroid cancerYves Denizot, Thierry Chianéa, François Labrousse, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Decrease in Fas-induced apoptosis by the γ-secretase inhibitor is dependent on p75(NTR) in a glioblastoma cell lineBarbara Bessette, Karine Durand, Stéphanie Giraud, et al.
Pageof 12